NOX 1.52% 6.7¢ noxopharm limited

Ann: Veyonda and Opdivo IONIC Study First Patient Dosed, page-13

  1. 580 Posts.
    lightbulb Created with Sketch. 355
    Here's some good news! The IONIC study is now listed on ANZ CTR. This confirms it will move into a expansion phase II. And confirms it is funded by Bristol Myers Squibb and NOX.

    That makes the 4th phase II that NOX66 has started and/or completed: LUPIN, CEP-2, DARRT-2, and now IONIC.

    https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382578
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.7¢
Change
0.001(1.52%)
Mkt cap ! $19.57M
Open High Low Value Volume
6.7¢ 6.7¢ 6.7¢ $818 12.21K

Buyers (Bids)

No. Vol. Price($)
1 17790 6.7¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 4049 1
View Market Depth
Last trade - 15.44pm 12/07/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.